5 Of Friday's Biggest Marijuana Stock Losers

TM editors' note: This article discusses one or more penny stocks and/or microcaps. Such stocks are easily manipulated; do your own careful due diligence.  

Out of over 200+ marijuana stocks, here are just 5 of the biggest marijuana stock losers in trading on Friday, August 10th including AXIM Biotechnologies, Inc. (OTC: AXIM) and more... 

AXIM Biotechnologies, Inc. (OTC: AXIM )

Shares of AXIM Biotechnologies, Inc. dropped 4.30% today on lower than the average trading volume on the OTC markets, closing the day at $2.45 USD per share. Recently, Axim announced positive results from stability and dissolution tests performed on its prime drug candidate, MedChew Rx®.

General Cannabis Corp. (OTC: CANN )

Shares of General Cannabis Corp. dropped 7.66% on higher than the average trading volume on the OTC markets, closing the day at $2.17 USD per share. Recently, General Cannabis announced financial results for the quarter ended June 30, 2018.

Organigram Holdings Inc. (TSXV: OGI) (OTC: OGRMF )

Shares of Organigram Holdings Inc. dropped 6.13% on higher than the average trading volume on the OTC markets, closing the day at $3.74776 USD per share. Recently, Organigram announced it will provide funding to Mount Allison to support the University's efforts to ensure the new legislation is fully communicated on campus.

Terra Tech Corp. (OTC: TRTC )

Shares of Terra Tech Corp. dropped 7.29% on higher than the average trading volume on the OTC markets, closing the day at $1.845 USD per share. Yesterday, Terra Tech announced its second quarter financial results for the period ended June 30, 2018.

Tetra Bio-Pharma Inc. (TSXV: TBP) (OTC: TBPMF )

Shares of Tetra Bio-Pharma Inc. dropped 5.79% on higher than the average trading volume on the OTC markets, closing the day at $0.56 USD per share. Recently, Tetra Bio-Pharma announced that Health Canada has approved its protocol for a clinical trial investigating its PPP001 drug as an alternative to the opioid fentanyl in the management of breakthrough cancer pain.

Disclaimer: Except for the historical information and data presented herein, matters discussed in articles on this website contain forward-looking statements that are subject to certain risks ...

more
How did you like this article? Let us know so we can better customize your reading experience. Users' ratings are only visible to themselves.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.